VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 4 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,890 | -55.7% | 30,530 | -1.2% | 0.00% | -75.0% |
| Q3 2020 | $298,000 | +22.6% | 30,900 | +108.8% | 0.00% | +100.0% |
| Q4 2019 | $243,000 | -46.4% | 14,800 | -56.6% | 0.00% | -33.3% |
| Q3 2019 | $453,000 | +19.2% | 34,100 | +26.5% | 0.00% | -25.0% |
| Q2 2019 | $380,000 | -75.0% | 26,955 | -59.2% | 0.00% | -73.3% |
| Q3 2018 | $1,518,000 | -53.6% | 66,111 | -65.9% | 0.02% | -42.3% |
| Q1 2018 | $3,270,000 | – | 194,070 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |